Search research articles

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Metastasis

Metastasis

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Localization of p210 BCR-ABL to the Mitochondria Promotes Chronic Myeloid Leukemia Cell Proliferation Through cIAP Signaling.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026

Same author

Identification and characterization of peptidyl-prolyl isomerase Pin1 as a new regulatory component of BCR::ABL1 degradation.

Leukemia research·2025

Same author

S100A8 as a potential therapeutic target for cancer metastasis.

Cancer science·2024

Same author

Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway.

Cancer gene therapy·2023

Same author

Variant spectrum of PIEZO1 and KCNN4 in Japanese patients with dehydrated hereditary stomatocytosis.

Human genome variation·2023

Same author

The Sympathetic Nervous System Contributes to the Establishment of Pre-Metastatic Pulmonary Microenvironments.

International journal of molecular sciences·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 31, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

The lung metastatic niche.

Journal of Molecular Medicine (Berlin, Germany)

|October 23, 2015

Summary

Primary tumors hijack the innate immune system to create lung pre-metastatic niches. Tumor-produced CCL2 triggers inflammation via Toll-like receptor 4 (TLR4), which can be inhibited by Eritoran.

Area of Science:

Oncology
Immunology
Cell Biology

Background:

Cancer metastasis requires tumor cells to survive in foreign environments and evade immune surveillance.
Lung metastatic niches, potentially formed before or after tumor cell arrival, aid tumor cell survival.
Primary tumors can induce inflammation in the lungs, recruiting myeloid cells to establish these niches.

Purpose of the Study:

To investigate the role of the Toll-like receptor 4 (TLR4)-dependent innate immune system in pre-metastatic niche formation.
To elucidate how primary tumors hijack endogenous inflammatory pathways to create lung metastatic environments.
To assess the potential of inhibiting pre-metastatic niche formation using an endotoxin analog.

Main Methods:

Analysis of primary tumor-derived factors and their effect on lung chemokine expression.

More Related Videos

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

Related Experiment Videos

Last Updated: Mar 31, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis

Published on: June 26, 2016

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

Investigation of myeloid cell recruitment and interaction with lung-resident cells.

Assessment of Toll-like receptor 4 (TLR4) activation and its downstream inflammatory effects.

Evaluation of the impact of the chemokine CCL2 on endogenous TLR4 ligand expression (S100A8, SAA3).

Testing the efficacy of the endotoxin analog Eritoran in inhibiting pre-metastatic niche formation.

Main Results:

Primary tumors induce pulmonary chemokine expression, recruiting bone marrow-derived myeloid cells.
The endogenous Toll-like receptor 4 (TLR4) pathway, normally involved in infection response, is hijacked by tumors.
Tumor-produced CCL2 drives lung inflammation by upregulating TLR4 ligands (S100A8, SAA3), mimicking endotoxin effects.
The endotoxin analog Eritoran demonstrated inhibition of pre-metastatic niche formation in this model.

Conclusions:

Primary tumors exploit the innate immune system, specifically the TLR4 pathway, to establish lung pre-metastatic niches.
CCL2-mediated inflammation is a key mechanism by which tumors prepare the lung microenvironment for metastasis.
Targeting TLR4-dependent inflammation with agents like Eritoran shows promise for preventing lung metastasis.